Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Borer Chemie is a private Swiss specialty chemical company that develops, manufactures, and commercializes advanced cleaning and disinfection solutions for hospitals, laboratories, pharmaceutical production, biotechnology, and industrial manufacturing. The company is best known for its deconex and decosept branded product lines, which are used for medical device reprocessing, laboratory glassware cleaning, validated cleaning in pharma and biotech production, and hand and surface disinfection. In life sciences, Borer positions itself as a process and application specialist, offering residue-free cleaning products, cleaning validation support, process development, technical support, and test-center services rather than a therapeutic drug pipeline. The company manufactures its products at its Swiss headquarters and distributes globally through subsidiaries, partners, and direct sales. Borer Chemie is healthcare-related, but it is not a drug developer; it operates primarily as a commercial provider of cleaning, decontamination, hygiene, and validated process solutions for regulated environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Borer Chemie.